Amy E Rothberg, MD, DABOM
Manage Your Profile
About
Amy E. Rothberg, MD, DABOM is Clinical Professor of Medicine in the Division of Metabolism, Endocrinology and Diabetes and Professor of Nutritional Sciences in the School of Public Health at the University of Michigan. She is the Director of the University of Michigan Weight Management Program, a 2-year intensive behavioral and lifestyle program onto which there is a multifaceted research program in which patients undergo extensive baseline and interval phenotyping to identify the factors that predict successful and cost-effective long-term weight loss. Her primary research is funded by the NIH/NIDDK. Her work encompasses three major research foci: The first is on the impact of the interventions on insulin secretion, insulin action, long-term glycemia, the development of complications and comorbidities, health-related quality-of-life, and cost. The second is on the behavioral and biological determinants of weight loss and weight loss maintenance. The third is scalability of her program through telehealth and the internet and the impact on the processes and outcomes of care.
Qualifications
-
ResidencyUniversity of Michigan, Internal Medicine, Ann Arbor, United States
Residency
Center Memberships
-
Center MemberCaswell Diabetes Institute
Research Overview
- Determining factors that predict successful and cost-effective long-term weight loss
- Assessing the neurobiopsychosocial adaptations that occur with weight loss
- Evaluating implementation of a model of intensive behavioral therapy from sub-speciality care into primary care
- Impact of weight loss on health related quality of life
- Effects of intensive lifestyle intervention on reproductive, maternal and fetal outcomes
Recent Publications
-
Melville N. 2026 Apr 9;Additional ScholarshipJCEM study quoted in Medscape article, "Concerns Continue Over Proposed New Obesity Definitions"
-
Eichstaedt J, Rothberg A, Burghardt P, Homayouni R, Stanley J. Biological Psychiatry, 2026 Apr 28; 99 (10): s175 - s176.Journal Article179. Evidence of Stimuli Type Influencing Inhibitory Control Ability in Individuals With Overweight or Obesity: A Meta-Analysis of Go/No-Go Behavioral Studies
DOI:10.1016/j.biopsych.2026.03.413 -
Muniyappa R, Chukir T, Desai D, Weintraub MA, Corrigan MD, Gianchandani R, Rothberg AE. J Clin Endocrinol Metab, 2026 Apr 2;Journal ArticleDefining disease or delaying care? A conceptual and clinical appraisal of the Lancet obesity framework.
DOI:10.1210/clinem/dgag097 PMID: 41925581 -
Monostra M. 2026 Apr 9;Additional ScholarshipJCEM study quoted in Endocrine Today article, “Endocrine Society communication outlines limitations of Lancet Commission obesity report”
-
Monaco K. 2026 Apr 9;Additional ScholarshipJCEM study quoted in Medpage article, “Proposed Obesity Criteria Could Delay Care, Top Society Warns"
-
Rothberg A. 2026 Apr 13;PresentationTheory to Application, Application to Insight: The interplay of Research and Practice
-
Rothberg A. 2026 Mar 20;Additional Scholarship"Four-Drug Regimen Superior to Escalating Metformin in T2D: EFFORT Trial”, Medscape
-
Rothberg A. 2026 Mar 20;Additional Scholarship"Four-Drug Regimen Superior to Escalating Metformin in T2D: EFFORT Trial”, Medscape
Featured News & Stories
New Findings on Obesity Identification by BMI Without Diagnosis